Martin Neuenschwander

7PUBLICATIONS

43CO-AUTHORS

Cheminformatics and quantitative structure-activity relationshipsPharmacogenomicsProteins and peptidesPowder and particle technology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 11, 2026

Discovery and characterization of a novel class of cyclic peptidic compounds inhibiting the subunit interaction of the protein kinase CK2α<sub>2</sub>β<sub>2</sub> holoenzyme.

|Jun 02, 2025

Inhibition of the Clathrin Terminal Domain-Amphiphysin Protein-Protein Interaction. Probing the Pitstop 2 Aromatic Moiety.

Kate Prichard, Mark J Robertson, Ngoc Chau

|Oct 16, 2023

An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor.

Tim Aguirre, Gillian L Dornan, Sarah Hostachy

|Nov 11, 2022

Glycolytic flux control by drugging phosphoglycolate phosphatase.

Elisabeth Jeanclos, Jan Schlötzer, Kerstin Hadamek

|Sep 15, 2022

Development of selective inhibitors of phosphatidylinositol 3-kinase C2α.

Wen-Ting Lo, Hassane Belabed, Murat Kücükdisli

|Apr 17, 2020

Revealing cytotoxic substructures in molecules using deep learning.

Henry E Webel, Talia B Kimber, Silke Radetzki

Pageof 2

Frequent Collaborators

Marc Nazaré

Volker Haucke

André Horatscheck

Christian Fetzer

Stephan A Sieber

Henry E Webel

Talia B Kimber

Silke Radetzki

Andrea Volkamer

Yohei Ohashi

Frequent Collaborators

Marc Nazaré

Volker Haucke

André Horatscheck

Christian Fetzer